Jenburkt Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lacs)
Jenburkt Pharmaceuticals Ltd · Financial Result · 03 Nov 2026, 11:26 pm
Jenburkt Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lacs) ■ Revenue: 4,832 (+6.1% YoY | +36.1% QoQ) ■ EBITDA: 1,302 (-0.7% YoY | +116.0% QoQ) ■ EBITDA Margin (%): 26.9 (-183 bps YoY | +997 bps QoQ) ■ PAT: 1,021 (+0.5% YoY | +73.5% QoQ) ■ EPS (INR): 23.1 (+0.4% YoY | +73.4% QoQ)
Original exchange filing (PDF)
More announcements from Jenburkt Pharmaceuticals Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Counter Cyclical Investment Pvt Ltd · 04 Nov 2026
- Outcome of the Board Meeting held today on 03rd November, 2026. · 03 Nov 2026
- Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Standalone Unaudited .... · 03 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Counter Cyclical Investment Pvt Ltd · 12 Oct 2026
- Intimation regarding admission of Equity shares of the Company under " Permitted to trade" category on National Stock Exchange of India Limited. · 22 Sept 2026
- Intimation about Resignation of a Senior Management Personnel of the Company. · 18 Sept 2026
- Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April, 2027 to 31st March, 2032, Approved with requisite .... · 05 Sept 2026
- Submission of consolidated Voting Results and Scrutinizer''s Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the Company held on 04th September, 2026. · 05 Sept 2026
